2016 ADX
2016 ADX Banner
Archived Content

Emerging Diagnostic Partnering and Investment Forum 

The pace of innovation, both technically and in terms of commercialization strategies, continues to accelerate within the field of molecular diagnostics, making the right strategic partnerships critical to the development of promising new technologies and applications. CHI's Emerging Diagnostic Partnering & Investment Forum will bring together exciting early stage companies with decision makers representing pharma, larger biotechs, and VCs, providing an efficient opportunity to learn about emerging technologies and engage in networking, partnering and investment exploration discussions. 

August 19, 2012 | View Agenda | Download Partnering Forum Brochure 

 about the latest tools, platforms and applications in molecular diagnostics

HEAR from innovative technology developers working in cancer, infectious disease and other therapeutic areas

DISCUSS strategies to leverage alliances and partnerships to bring diagnostics to market

NETWORK with early stage companies, established diagnostic and platform companies, clinical labs and investors

EXPLORE potential partnership opportunities through one-on-one meetings

MAXIMIZE your experience on site with Partner Direct networking software

Partner DirectPartner Direct is an online networking tool designed to facilitate collaboration amongst emerging companies and potential strategic partners. This partnering software provides the opportunity for forum delegates to connect with company presenters in advance to schedule one-on-one meetings during the event.

Partner Direct will be available to registered attendees of the Emerging Diagnostic Partnering & Investment Forum starting ix weeks before the event, and will remain accessible during and after the forum to allow you to make the most of your time on site.


Brian T. Edmonds, Ph.D., Director, New Technologies, Global External Research & Development, Lilly Corporate Center
Jorge Leon, Ph.D., President, Leomics Consulting
Daniel R. McClernon, McClernon LLC
Charlie Raffin, Consultant
David Rubin, Ph.D., Senior Director, Global Health Innovation Group, Merck & Co.
Ali Tinazli, Director, Business Development & Sales, BioSciences - North America, Sony DADC Austria AG
Katherine Tynan, Ph.D., Business Development & Strategic Consulting for Diagnostics Companies, Tynan Consulting LLC
Penny Wilson, Ph.D., Innovation Platform Leader, Stratified Medicine, Technology Strategy Board


Delegate Profile 




Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

2016 Brochure

2016 Next Generation Dx Summit Brochure

ADX 2016 CAG Brochure Icon

Premier Sponsors


Positive ID

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products